Ironwood Pharmaceuticals (IRWD) Shareholder Broderick Brian C Boosted Position by $4.80 Million as Share Value Declined; Kistler-Tiffany Companies Holding in West Pharmaceutical Svsc (WST) Lowered as Stock Value Declined

April 20, 2018 - By Linda Rogers

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Logo

Broderick Brian C increased its stake in Ironwood Pharmaceuticals (IRWD) by 237.13% based on its latest 2017Q4 regulatory filing with the SEC. Broderick Brian C bought 342,589 shares as the company’s stock declined 1.30% with the market. The institutional investor held 487,065 shares of the health care company at the end of 2017Q4, valued at $7.30 million, up from 144,476 at the end of the previous reported quarter. Broderick Brian C who had been investing in Ironwood Pharmaceuticals for a number of months, seems to be bullish on the $2.60 billion market cap company. The stock decreased 2.11% or $0.37 during the last trading session, reaching $17.2. About 940,700 shares traded. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has declined 11.53% since April 20, 2017 and is downtrending. It has underperformed by 23.08% the S&P500.

Kistler-Tiffany Companies Llc decreased its stake in West Pharmaceutical Svsc Inc (WST) by 17.3% based on its latest 2017Q4 regulatory filing with the SEC. Kistler-Tiffany Companies Llc sold 11,240 shares as the company’s stock declined 13.33% with the market. The institutional investor held 53,716 shares of the basic industries company at the end of 2017Q4, valued at $5.30 million, down from 64,956 at the end of the previous reported quarter. Kistler-Tiffany Companies Llc who had been investing in West Pharmaceutical Svsc Inc for a number of months, seems to be less bullish one the $6.74B market cap company. The stock decreased 0.71% or $0.65 during the last trading session, reaching $91.11. About 96,119 shares traded. West Pharmaceutical Services, Inc. (NYSE:WST) has risen 6.37% since April 20, 2017 and is uptrending. It has underperformed by 5.18% the S&P500.

Analysts await West Pharmaceutical Services, Inc. (NYSE:WST) to report earnings on April, 26 before the open. They expect $0.65 EPS, up 8.33% or $0.05 from last year’s $0.6 per share. WST’s profit will be $48.07 million for 35.04 P/E if the $0.65 EPS becomes a reality. After $0.64 actual EPS reported by West Pharmaceutical Services, Inc. for the previous quarter, Wall Street now forecasts 1.56% EPS growth.

Among 6 analysts covering West Pharmaceutical Services (NYSE:WST), 3 have Buy rating, 0 Sell and 3 Hold. Therefore 50% are positive. West Pharmaceutical Services had 15 analyst reports since August 4, 2015 according to SRatingsIntel. Jefferies maintained West Pharmaceutical Services, Inc. (NYSE:WST) on Monday, September 11 with “Hold” rating. The stock of West Pharmaceutical Services, Inc. (NYSE:WST) has “Outperform” rating given on Tuesday, March 22 by Wells Fargo. The rating was initiated by Janney Capital on Friday, January 8 with “Buy”. The stock has “Hold” rating by Zacks on Tuesday, August 4. On Thursday, June 29 the stock rating was maintained by Jefferies with “Hold”. Wells Fargo maintained West Pharmaceutical Services, Inc. (NYSE:WST) rating on Friday, October 27. Wells Fargo has “Outperform” rating and $112 target. As per Friday, October 28, the company rating was upgraded by Wells Fargo. The stock of West Pharmaceutical Services, Inc. (NYSE:WST) has “Buy” rating given on Thursday, February 15 by Jefferies. Bank of America downgraded it to “Hold” rating and $98.0 target in Tuesday, October 17 report. The rating was downgraded by Wells Fargo to “Market Perform” on Wednesday, September 21.

Investors sentiment decreased to 1.17 in 2017 Q4. Its down 0.16, from 1.33 in 2017Q3. It dived, as 19 investors sold WST shares while 97 reduced holdings. 48 funds opened positions while 88 raised stakes. 67.16 million shares or 1.36% less from 68.09 million shares in 2017Q3 were reported. Invesco Limited holds 0.01% or 349,447 shares. Shelton Mngmt owns 0.04% invested in West Pharmaceutical Services, Inc. (NYSE:WST) for 5,531 shares. Ruane Cunniff And Goldfarb Incorporated reported 0.02% in West Pharmaceutical Services, Inc. (NYSE:WST). Neuberger Berman Gru Limited Liability Co accumulated 3.41 million shares. Thrivent Financial For Lutherans owns 137,104 shares. Swiss Financial Bank has 126,000 shares for 0.01% of their portfolio. Moreover, Connable Office Incorporated has 0.07% invested in West Pharmaceutical Services, Inc. (NYSE:WST). Mutual Of America Capital Limited Liability stated it has 60,939 shares or 0.09% of all its holdings. Verition Fund Management Lc owns 4,136 shares. World Asset Management holds 0.02% of its portfolio in West Pharmaceutical Services, Inc. (NYSE:WST) for 5,128 shares. Advantus Cap Incorporated invested in 0.02% or 9,145 shares. Jane Street Grp Limited Liability stated it has 6,307 shares or 0% of all its holdings. Amer Interest Gp has 0.05% invested in West Pharmaceutical Services, Inc. (NYSE:WST). Greenleaf Trust owns 349 shares. 1832 Asset Lp accumulated 713,360 shares.

Kistler-Tiffany Companies Llc, which manages about $559.78 million and $253.25 million US Long portfolio, upped its stake in Vanguard Index Fds (VV) by 6,637 shares to 346,154 shares, valued at $42.43 million in 2017Q4, according to the filing. It also increased its holding in Ishares Tr (IJH) by 2,307 shares in the quarter, for a total of 32,531 shares, and has risen its stake in Ishares Tr (IBB).

Since December 8, 2017, it had 0 buys, and 1 insider sale for $2.08 million activity.

Since January 24, 2018, it had 0 buys, and 7 insider sales for $1.22 million activity. Another trade for 1,634 shares valued at $23,954 was sold by Currie Mark G. McHugh Julie had sold 1,500 shares worth $21,090 on Monday, March 5. 3,594 Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) shares with value of $52,688 were sold by Consylman Gina. Another trade for 7,741 shares valued at $113,483 was made by Gilbert Halley E on Wednesday, February 21. $49,008 worth of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) was sold by MCCOURT Thomas A on Wednesday, February 21.

Broderick Brian C, which manages about $273.95M US Long portfolio, decreased its stake in Fiserv (NASDAQ:FISV) by 3,684 shares to 51,382 shares, valued at $6.74 million in 2017Q4, according to the filing. It also reduced its holding in Intel Corp (NASDAQ:INTC) by 12,301 shares in the quarter, leaving it with 140,698 shares, and cut its stake in Abbott Labs (NYSE:ABT).

Among 15 analysts covering Ironwood Pharmaceuticals (NASDAQ:IRWD), 4 have Buy rating, 2 Sell and 9 Hold. Therefore 27% are positive. Ironwood Pharmaceuticals had 38 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Buy” rating by Cowen & Co given on Wednesday, November 1. The company was downgraded on Friday, July 21 by J.P. Morgan. Wedbush maintained Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) on Friday, February 19 with “Neutral” rating. The stock of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has “Outperform” rating given on Wednesday, April 6 by Cowen & Co. The firm has “Buy” rating given on Thursday, July 20 by Mizuho. The stock of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has “Buy” rating given on Thursday, July 20 by Cowen & Co. Mizuho maintained it with “Buy” rating and $2200 target in Tuesday, June 6 report. The firm has “Buy” rating by BTIG Research given on Friday, December 11. The rating was maintained by Cowen & Co on Friday, August 4 with “Buy”. The rating was downgraded by Zacks on Monday, August 10 to “Hold”.

Investors sentiment decreased to 1.05 in 2017 Q4. Its down 0.20, from 1.25 in 2017Q3. It dived, as 18 investors sold IRWD shares while 44 reduced holdings. 21 funds opened positions while 44 raised stakes. 149.98 million shares or 2.99% less from 154.60 million shares in 2017Q3 were reported. Credit Suisse Ag, a Switzerland-based fund reported 1.57M shares. Lpl Finance Llc invested 0% in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Geode Management Limited Liability has invested 0.01% in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Tiaa Cref Mngmt Limited Liability Corporation accumulated 329,399 shares. Legal & General Gru Public Ltd Liability Com reported 0% stake. Capital World Invsts reported 1.33 million shares or 0% of all its holdings. Amer Intl has 0% invested in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Voya Investment Limited Co has 0% invested in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) for 61,273 shares. Fifth Third National Bank holds 0% in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) or 2,130 shares. Manufacturers Life Com The, Ontario – Canada-based fund reported 103,462 shares. Pacad Investment invested in 0.03% or 8,101 shares. Strs Ohio has invested 0% in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Impact Advsr Ltd Liability Co reported 0.6% in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Denver Inv Advsrs Ltd Co has invested 0.02% of its portfolio in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD). Plante Moran Advsr Limited Liability Corporation holds 79 shares.

West Pharmaceutical Services, Inc. (NYSE:WST) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>